These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2965205)

  • 21. Dopaminergic control of the rat thyrotroph.
    Price J; Grossman A; Besser GM; Rees LH
    Neuroendocrinology; 1983 Feb; 36(2):125-9. PubMed ID: 6132345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
    Robertson GS; Robertson HA
    Brain Res; 1986 Oct; 384(2):387-90. PubMed ID: 2946360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for alpha 1-adrenergic stimulatory control of in vitro release of immunoreactive thyrotropin-releasing hormone from rat median eminence: in vivo corroboration.
    Tapia-Arancibia L; Arancibia S; Astier H
    Endocrinology; 1985 Jun; 116(6):2314-9. PubMed ID: 2986944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin.
    Russell SH; Kim MS; Small CJ; Abbott CR; Morgan DG; Taheri S; Murphy KG; Todd JF; Ghatei MA; Bloom SR
    J Neuroendocrinol; 2000 Dec; 12(12):1213-8. PubMed ID: 11106980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for the presence of D2 but not D1 dopamine receptors in rat hypothalamic perifornical area.
    Pizzi M; Coen E; Memo M; Missale C; Carruba MO; Spano PF
    Neurosci Lett; 1986 Jun; 67(2):159-62. PubMed ID: 2941702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of neurotransmitters on the in vitro release of immunoreactive thyrotropin-releasing hormone from rat mediobasal hypothalamus.
    Joseph-Bravo P; Charli JL; Palacios JM; Kordon C
    Endocrinology; 1979 Mar; 104(3):801-6. PubMed ID: 35337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of dopamine and morphine on immunoreactive somatostatin and LH-releasing hormone secretion from hypothalamic fragments in vitro.
    Lengyel AM; Grossman A; Bouloux PM; Rees LH; Besser GM
    J Endocrinol; 1985 Sep; 106(3):317-22. PubMed ID: 2864381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excitatory neuronal responses to dopamine in the cerebral cortex: involvement of D2 but not D1 dopamine receptors.
    Bradshaw CM; Sheridan RD; Szabadi E
    Br J Pharmacol; 1985 Oct; 86(2):483-90. PubMed ID: 2932196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rigional differences in dopamine-mediated release of TRH-like material from synaptosomes.
    Schaeffer JM; Axelrod J; Brownstein MJ
    Brain Res; 1977 Dec; 138(3):571-4. PubMed ID: 23203
    [No Abstract]   [Full Text] [Related]  

  • 31. The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors.
    Santiago M; Westerink BH
    Eur J Pharmacol; 1991 Oct; 204(1):79-85. PubMed ID: 1687125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK; Manzino L; Heikkila RE
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of guanine nucleotide-binding proteins, Gi alpha 3 and Gs alpha, in dopamine and thyrotropin-releasing hormone signal transduction: evidence for competition and commonality.
    Kineman RD; Gettys TW; Frawley LS
    J Endocrinol; 1996 Mar; 148(3):447-55. PubMed ID: 8778223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine D2 receptor stimulation inhibits inositol phosphate generating system in rat striatal slices.
    Pizzi M; Da Prada M; Valerio A; Memo M; Spano PF; Haefely WE
    Brain Res; 1988 Jul; 456(2):235-40. PubMed ID: 2974746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. D2-dopamine receptors regulate the release of [3H]dopamine in rat basal hypothalamus and neurointermediate lobe of the pituitary gland.
    Plantjé JF; Schipper J; Verheijden PF; Stoof JC
    Brain Res; 1987 Jun; 413(2):205-12. PubMed ID: 2955852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM; Fernández M; Jantos H
    Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures.
    Turski WA; Cavalheiro EA; Ikonomidou C; Bortolotto ZA; Klockgether T; Turski L
    Synapse; 1990; 5(2):113-9. PubMed ID: 2137942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopaminergic control of angiotensin II-induced vasopressin secretion in vitro.
    Rossi NF
    Am J Physiol; 1998 Oct; 275(4):E687-93. PubMed ID: 9755089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of growth hormone-releasing hormone and corticotropin-releasing hormone on the release of thyrotropin-releasing hormone from the rat hypothalamus in vitro.
    Mitsuma T; Nogimori T; Hirooka Y
    Exp Clin Endocrinol; 1987 Dec; 90(3):365-8. PubMed ID: 3131150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of dopaminergic blockade on thyrotrophin response to thyrotrophin-releasing hormone and somatostatin.
    Sánchez A; Montoya E
    Horm Metab Res; 1987 Dec; 19(12):604-5. PubMed ID: 2894340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.